# CLNK

## Overview
The CLNK gene encodes the cytokine-dependent hematopoietic cell linker, an adaptor protein that plays a pivotal role in immune cell signaling. This protein is a member of the SLP-76 family of adaptors and is primarily involved in linking cytokine receptors to downstream signaling pathways, which are essential for the activation and differentiation of immune cells (Yu2001Synergistic; Cao1999Clnk). The protein is predominantly expressed in cytokine-stimulated cells, including T cells, natural killer cells, and mast cells, where it enhances signaling events initiated by antigen receptors (Yu2001Synergistic; Cao1999Clnk). Through its interactions with various signaling molecules, such as hemopoietic protein kinase 1 (HPK-1) and phospholipase Cγ (PLCγ), CLNK plays a crucial role in orchestrating immune responses, thereby contributing to the regulation of immune cell function and the maintenance of immune homeostasis (Yu2001Synergistic; Goitsuka2000A).

## Structure


## Function
The CLNK gene encodes an adaptor protein that plays a significant role in immunoreceptor signaling within hematopoietic cells. This protein is part of the SLP-76 family of adaptors and is involved in linking cytokine receptors to downstream signaling pathways, crucial for immune cell activation and differentiation (Yu2001Synergistic; Cao1999Clnk). CLNK is primarily expressed in cytokine-stimulated cells, such as T cells, natural killer cells, and mast cells, where it enhances signaling events triggered by antigen receptors (Yu2001Synergistic; Cao1999Clnk).

In T cells, CLNK interacts with the serine/threonine protein kinase HPK-1, enhancing its activity and promoting the activation of the IL-2 promoter, a key event in T-cell activation (Yu2001Synergistic). This interaction suggests that CLNK can substitute for SLP-76 in T-cell signaling, despite utilizing different intracellular effectors (Yu2001Synergistic). CLNK's role in immune responses is further highlighted by its ability to modulate the phosphorylation state of HPK-1, influencing signaling pathways in hemopoietic cells (Yu2001Synergistic).

Overall, CLNK is a crucial component in the regulation of immune cell signaling, contributing to the proper functioning of immune responses by facilitating the activation of key signaling pathways in response to cytokine and antigen receptor stimulation.

## Clinical Significance
The CLNK gene has been implicated in several diseases and conditions due to its role in immune cell signaling. Genetic variations in CLNK have been associated with an increased risk of gout. Specifically, SNPs such as rs2041215 and rs16869474 in the CLNK gene have been linked to a higher likelihood of developing gout, with rs16869474 remaining significant after Bonferroni correction (Jin2015Genetic). 

CLNK is also involved in the pathophysiology of type 2 diabetes mellitus (T2DM), where elevated serum levels of CLNK correlate with the duration of the disease. This suggests that CLNK may contribute to the low-grade inflammation associated with T2DM, potentially affecting insulin resistance (AlFadhel2020Serum). 

In transfusion-dependent beta-thalassemia (TDT), CLNK levels are significantly elevated and correlate with iron overload biomarkers, indicating a role in the disease's immune signaling and erythrocyte function (AlHakeim2021Cytokine). 

Additionally, CLNK has been associated with generalized vitiligo, an autoimmune condition, suggesting its involvement in immune system regulation and susceptibility to autoimmune diseases (Zhang2014Genetic). These associations highlight the clinical significance of CLNK in various immune-related disorders.

## Interactions
CLNK, also known as MIST, is an adaptor protein involved in various protein interactions crucial for immune cell signaling. It interacts with hemopoietic protein kinase 1 (HPK-1), a serine/threonine-specific protein kinase, enhancing its kinase activity and influencing its cellular localization or substrate specificity. This interaction is pivotal for the synergistic regulation of immunoreceptor signaling, particularly in T cells and myeloid cells (Yu2001Synergistic).

CLNK also associates with phospholipase Cγ (PLCγ), Vav, Grb2, and the linker for activation of T cells (LAT) in mast cells, playing a role in FcεRI-mediated degranulation. These interactions are essential for the signaling pathway leading to mast cell degranulation (Goitsuka2000A). The protein's SH2 domain facilitates binding with ADAP (also known as Fyb or SLAP-130) and HPK-1, indicating its role in orchestrating signals for immunoreceptor signaling (Utting2004Immune).

CLNK's interaction with HPK-1 is enhanced by tyrosine phosphorylation, which is mediated by Src family kinases such as Lyn. This phosphorylation is crucial for CLNK's role in immune signaling pathways (Arnold2005Activation; Xu2015Clnk).


## References


[1. (Yu2001Synergistic) Jie Yu, Catherine Riou, Dominique Davidson, Raman Minhas, Jeffrey D. Robson, Michael Julius, Ruediger Arnold, Friedemann Kiefer, and André Veillette. Synergistic regulation of immunoreceptor signaling by slp-76-related adaptor clnk and serine/threonine protein kinase hpk-1. Molecular and Cellular Biology, 21(18):6102–6112, September 2001. URL: http://dx.doi.org/10.1128/MCB.21.18.6102-6112.2001, doi:10.1128/mcb.21.18.6102-6112.2001. This article has 60 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.21.18.6102-6112.2001)

[2. (AlHakeim2021Cytokine) H.K. Al-Hakeim, H.H. Al-Mayali, S.R. Moustafa, and M. Maes. Cytokine dependent hematopoietic cell linker (clnk) is highly elevated in blood transfusion dependent beta-thalassemia major patients. Transfusion Clinique et Biologique, 28(2):194–198, May 2021. URL: http://dx.doi.org/10.1016/j.tracli.2021.01.003, doi:10.1016/j.tracli.2021.01.003. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.tracli.2021.01.003)

[3. (Arnold2005Activation) Rüdiger Arnold, Irene M. Patzak, Brit Neuhaus, Sadia Vancauwenbergh, André Veillette, Johan Van Lint, and Friedemann Kiefer. Activation of hematopoietic progenitor kinase 1 involves relocation, autophosphorylation, and transphosphorylation by protein kinase d1. Molecular and Cellular Biology, 25(6):2364–2383, March 2005. URL: http://dx.doi.org/10.1128/mcb.25.6.2364-2383.2005, doi:10.1128/mcb.25.6.2364-2383.2005. This article has 55 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.25.6.2364-2383.2005)

[4. (Xu2015Clnk) Meng Xu, Chengfeng Cai, Xuli Sun, Wanze Chen, Qinxi Li, and Huamin Zhou. Clnk plays a role in tnf-alpha-induced cell death in murine fibrosarcoma cell line l929. Biochemical and Biophysical Research Communications, 463(3):275–279, July 2015. URL: http://dx.doi.org/10.1016/j.bbrc.2015.05.046, doi:10.1016/j.bbrc.2015.05.046. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2015.05.046)

[5. (Jin2015Genetic) Tian-bo Jin, Yongchao Ren, Xugang Shi, Mutu Jiri, Na He, Tian Feng, Dongya Yuan, and Longli Kang. Genetic variations in the clnk gene and znf518b gene are associated with gout in case–control sample sets. Rheumatology International, 35(7):1141–1147, January 2015. URL: http://dx.doi.org/10.1007/s00296-015-3215-3, doi:10.1007/s00296-015-3215-3. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00296-015-3215-3)

[6. (Utting2004Immune) Oliver Utting, Bradley J. Sedgmen, Tania H. Watts, Xiaoshu Shi, Robert Rottapel, Angelo Iulianella, David Lohnes, and André Veillette. Immune functions in mice lacking clnk, an slp-76-related adaptor expressed in a subset of immune cells. Molecular and Cellular Biology, 24(13):6067–6075, July 2004. URL: http://dx.doi.org/10.1128/MCB.24.13.6067-6075.2004, doi:10.1128/mcb.24.13.6067-6075.2004. This article has 34 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/MCB.24.13.6067-6075.2004)

[7. (AlFadhel2020Serum) Suhaer Zeki Al-Fadhel, Nibras H. Abdulsada Al-Ghuraibawi, Dunia M. Mohammed Ali, and Hussein Kadhem Al-Hakeim. Serum cytokine dependent hematopoietic cell linker (clnk) as a predictor for the duration of illness in type 2 diabetes mellitus. Journal of Diabetes &amp; Metabolic Disorders, 19(2):959–966, July 2020. URL: http://dx.doi.org/10.1007/s40200-020-00588-z, doi:10.1007/s40200-020-00588-z. This article has 4 citations.](https://doi.org/10.1007/s40200-020-00588-z)

[8. (Goitsuka2000A) Ryo Goitsuka, Hideki Kanazashi, Hiroki Sasanuma, Yu-ichi Fujimura, Yuri Hidaka, Akiko Tatsuno, Chisei Ra, Katsuhiko Hayashi, and Daisuke Kitamura. A bash/slp-76-related adaptor protein mist/clnk involved in ige receptor-mediated mast cell degranulation. International Immunology, 12(4):573–580, April 2000. URL: http://dx.doi.org/10.1093/intimm/12.4.573, doi:10.1093/intimm/12.4.573. This article has 39 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/intimm/12.4.573)

[9. (Cao1999Clnk) Ming Yu Cao, Dominique Davidson, Jie Yu, Sylvain Latour, and André Veillette. Clnk, a novel slp-76–related adaptor molecule expressed in cytokine-stimulated hemopoietic cells. The Journal of Experimental Medicine, 190(10):1527–1534, November 1999. URL: http://dx.doi.org/10.1084/jem.190.10.1527, doi:10.1084/jem.190.10.1527. This article has 50 citations.](https://doi.org/10.1084/jem.190.10.1527)

[10. (Zhang2014Genetic) Zheng Zhang and Leihong Flora Xiang. Genetic susceptibility to vitiligo: recent progress from genome-wide association studies. Dermatologica Sinica, 32(4):225–232, December 2014. URL: http://dx.doi.org/10.1016/j.dsi.2014.09.004, doi:10.1016/j.dsi.2014.09.004. This article has 8 citations and is from a poor quality or predatory journal.](https://doi.org/10.1016/j.dsi.2014.09.004)